In Re: Patanjali Ayurved Limited, Through Its Managing Director, Acharya Balkrishna & Baba Ramdev
Background
The Indian Medical Association had approached the Supreme Court alleging that Patanjali Ayurved, its Managing Director Acharya Balkrishna, and Baba Ramdev were running a sustained misinformation campaign disparaging modern (allopathic) medicine through misleading advertisements. In November 2023, the Court recorded an assurance from Patanjali that it would stop making false claims about the medicinal efficacy of its products and would not violate advertising laws. When Patanjali and its principals continued to issue such advertisements and held a press conference repeating the claims, the Court initiated suo motu contempt proceedings against them for breaching their own undertaking.
Decision Breakdown
The Court rejected an initial "conditional apology" that tried to justify the conduct while also apologising, holding that justification and apology cannot coexist. After the Court's rejection, Acharya Balkrishna and Baba Ramdev tendered an unconditional and unqualified apology on affidavit and in person, undertook not to repeat the violations, and published the apology prominently in national and regional newspapers (their first attempt at publishing it was rejected as being in illegible fine print). Weighing the initial contemptuous conduct against the subsequent genuine remedial steps (the apology, undertakings, and corrective publicity) the Court accepted the apology and closed the contempt proceedings, while sternly cautioning that any future breach would be dealt with strictly.
Lesson Learnt
Advertisers and public figures cannot make an "apology" conditional on self-justification. Courts expect genuine, unqualified contrition; and once a party gives the Supreme Court an undertaking, repeated or public violation of it can trigger contempt proceedings that only sincere corrective steps (not token gestures) can resolve.